Literature DB >> 23357607

Haemophilus parainfluenzae urethritis among homosexual men.

Meng-Shiuan Hsu1, Mei-Yu Wu1, Tsui-Hsien Lin2, Chun-Hsing Liao3.   

Abstract

Haemophilus parainfluenzae is a common inhabitant of the human upper respiratory tract of the normal oral microflora. We report three men who had been having unprotected sex with men (MSM) and subsequently acquired H. parainfluenzae urethritis, which was confirmed by 16S rRNA gene sequencing analysis. Two men were treated with ceftriaxone and doxycycline, and the third man was treated with clarithromycin. All three patients responded to treatment. This case series highlights the potential role of H. parainfluenzae as a sexually transmitted genitourinary pathogen.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  16S RNA; Haemophilus parainfluenzae; Urethritis

Mesh:

Substances:

Year:  2013        PMID: 23357607     DOI: 10.1016/j.jmii.2012.11.007

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  3 in total

1.  Emergence of extensively drug-resistant Haemophilus parainfluenzae in Switzerland.

Authors:  Regula Tinguely; Salome N Seiffert; Hansjakob Furrer; Vincent Perreten; Sara Droz; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

2.  Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain.

Authors:  Yanik Sierra; Aida González-Díaz; Fe Tubau; Arkaitz Imaz; Meritxell Cubero; Jordi Càmara; Josefina Ayats; Sara Martí; Carmen Ardanuy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-11       Impact factor: 3.267

3.  Identification of polysaccharide capsules among extensively drug-resistant genitourinary Haemophilus parainfluenzae isolates.

Authors:  Aida González-Díaz; Fe Tubau; Miguel Pinto; Yanik Sierra; Meritxell Cubero; Jordi Càmara; Josefina Ayats; Paula Bajanca-Lavado; Carmen Ardanuy; Sara Marti
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.